Evidence-Based Mini-Review: Treatment Options for Patients with Relapsed/Refractory Myeloma Previously Treated with Novel Agents and High-Dose Chemotherapy and Autologous Stem-Cell Transplantation-Reference-Cited by-同舟云学术

Evidence-Based Mini-Review: Treatment Options for Patients with Relapsed/Refractory Myeloma Previously Treated with Novel Agents and High-Dose Chemotherapy and Autologous Stem-Cell Transplantation

Published:2010-12-04 Issue:1 Volume:2010 Page:310-313
ISSN:1520-4391
Container-title:Hematology
language:en
Short-container-title:

Author:

Shah Nina¹,Lonial Sagar²

Affiliation:

1. Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX;

2. Winship Cancer Institute, Emory University, Atlanta, GA

Publisher

American Society of Hematology

Subject

Hematology

Link

http://ashpublications.org/hematology/article-pdf/2010/1/310/1493670/bep00110000310.pdf

Reference53 articles.

1. Improved survival in multiple myeloma and the impact of novel therapies;Kumar;Blood,2008

2. Toxicity of a second autologous peripheral blood stem cell transplant in patients with relapsed or recurrent multiple myeloma;Burzynski;Leuk Lymphoma,2009

3. Prolonged overall survival with second on-demand autologous transplant in multiple myeloma;Elice;Am J Hematol,2006

4. Second autologous transplantation for multiple myeloma patients relapsing after the first autograft – a pilot study for the evaluation of experimental maintenance therapies. Report of the prospective non-randomized pilot study of the Czech Myeloma Group;Krivanova;Onkologie,2004

5. Second auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma;Olin;Bone Marrow Transplant,2009

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Immune Cells and Immunotherapy in Multiple Myeloma;Life;2024-04-01

2. Applications and perspectives of nanomaterials in novel vaccine development;MedChemComm;2018

3. Protein Expression for Novel Prognostic Markers (Cyclins D1, D2, D3, B1, B2, ITGβ7, FGFR3, PAX5) Correlate With Previously Reported Gene Expression Profile Patterns in Plasma Cell Myeloma;Applied Immunohistochemistry & Molecular Morphology;2015-05

4. Role of Hematopoietic Stem Cell Transplantation in Multiple Myeloma;Clinical Lymphoma Myeloma and Leukemia;2015-02

5. Autologous Stem Cell Transplantation: An Effective Salvage Therapy in Multiple Myeloma;Biology of Blood and Marrow Transplantation;2013-03